Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer

INTRODUCTION: Concurrent chemoradiotherapy (cCRT) was the standard of care for patients with unresectable stage III non-small cell lung cancer (NSCLC) prior to the PACIFIC trial, however, patients also received single modality therapy. This study identified predictors of therapy and differences in o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobbili, Priyanka, Ryan, Kellie, DerSarkissian, Maral, Dua, Akanksha, Yee, Christopher, Duh, Mei Sheng, Gomez, Jorge E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080248/
https://www.ncbi.nlm.nih.gov/pubmed/32187231
http://dx.doi.org/10.1371/journal.pone.0230444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080248/
https://www.ncbi.nlm.nih.gov/pubmed/32187231
http://dx.doi.org/10.1371/journal.pone.0230444

Ejemplares similares